Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


Stability Testing in Pharmaceutical Development and Manufacturing

14 May 2013 - 15 May 2013 - London UK



Bookmark and Share


This course has been updated to reflect the recent changes in the pharmaceutical stability testing world.

The new course content will provide a comprehensive update on current trends which offer substantial potential savings in time and resources in a traditionally costly testing area. It will include opportunities for review of specific participant problems

The course will cover:

Recent regulatory changes affecting stability including

  • The implications of implementation of ICH Q7, Q8, Q9, Q10 and Q11 for stability testing
  • Changes to European GMP guidance with impact on stability testing including Annexe updates affecting product development, outsourcing and application of Quality Risk Management (QRM)
  • Product Quality Reviews and the interpretation of stability data.

Recent scientific developments with implications for stability, with a particular focus on cost reduction, shortening of development timelines, and improvements on existing interpretation systems

  • ASAP - using short term high stress testing to get accurate predictions of shelf life with a high degree of confidence - Freethink Technologies' ASAPprime
  • Low level impurities and their impact on product stability
  • Manipulation of tablet internal pH to improve product stability

Who Should Attend?

The course is designed for people working in:
  • Analytical Development
  • Analytical Chemistry
  • Stability Testing
  • Formulation Development
  • Regulatory Affairs
  • Pharmaceutical & Biopharmaceutical Production
  • Product Development
  • Technical Operations

Course Programme

DAY 1

The course will commence with registration and coffee at 8.30am, course proper at 9.00am and will finish at 5.00pm

Morning

Introductions

  • Quality by Design and the ICH updates QQ7, Q8, Q9, Q10 and Q11 - implications for stability testing

Afternoon

  • Changes to EU GMP guidance with implications for stability - Chapter 1 and Annexes
  • Product Quality Review and the interpretation of stability data
  • Delegate workshop - reviewing delegate-presented problems

DAY 2

Morning

  • Low level impurities and their impact on drug product stability.
  • ASAP - using short term, high stress testing to get accurate predictions of drug substance and drug product shelf life with high confidence using ASAPprime software
  • Bracketing and matrixing and accurate data interpretation, using the "Stability" software package from Arlenda

Afternoon

  • Manipulation of tablet internal pH to improve product stability
  • In Silico prediction of drug degradation pathways using the Zeneth software systems
  • Action Planning and Final Q&A. Delegates are encouraged to send data for analysis prior to the course

Additional Resources

Online access to comprehensive publications including all relevant guidance will be provided as well as colour copies of all presentations and case studies.



Further information
Scientific News
Oxygen Can Impair Cancer Immunotherapy in Mice
Researchers at NIH have discovered that the T cells contain a group of oxygen-sensing proteins which act to limit inflammation within the lungs.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Unravelling the Metastatic Mechanism of Melanoma
Research has uncovered the mechanism of melanoma spreading; the findings could lead to a cure for the disease.
Gene Therapy Via Ultrasound
Research into a gene therapy approach called sonoporation could help combat heart disease and cancer.
Novel MRI Technique Distinguishes Healthy Prostate Tissue from Cancer
The UTSW researchers have determined that glucose stimulates release of the zinc ions from inside epithelial cells, which they could then track on MRIs.
Precision Nanobots Target Cancerous Tumours
Researchers achieve breakthrough toward redefining anti-cancer drug administration using nanorobotics.
PARP Proteins Explore Therapeutic Targets in Cancer
Researchers at UTSW have identified a previously unknown role of a certain class of proteins that opens the door to explore therapeutic targets in cancer and other disease.
Novel Therapeutic Approach for Blood Disorders
Gene editing of human blood-forming stem cells mimics a benign genetic condition that helps to overcome sickle cell disease and other blood disorders.
Immune-Cell Population Predicts Immunotherapy Response in Melanoma
All patients with high levels of one immune-cell type responded to treatment.
Effects of Chemotherapy on Developing Ovaries in Female Fetuses
Researchers at University of Edinburgh have shown that etoposide can damage the development of the ovaries while a fetus is in the womb.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!